logo

Evoke Pharma, Inc. (EVOK)



Trade EVOK now with
  Date
  Headline
6/27/2019 8:45:54 AM Evoke Submits Type A Meeting Request To FDA To Discuss CRL On Gimoti
6/27/2019 8:34:05 AM Evoke Pharma Requests Type A FDA Meeting To Plan For Resubmission Of Gimoti NDA
4/2/2019 6:03:40 AM Evoke Pharma Receives Complete Response Letter And Recommendations To Address Deficiencies From FDA For Gimoti NDA
3/6/2019 8:40:24 AM Evoke Pharm Q4 Net Loss $1.8 Mln Or $0.10/shr Vs. Net Loss Of $0.3 Mln Or $0.02/shr Prior Year
8/16/2018 8:33:03 AM Evoke Pharma’s Gimoti NDA Accepted For FDA Review
6/4/2018 7:34:43 AM Evoke Announces FDA Submission Of NDA For Gimoti
5/14/2018 6:32:21 AM Evoke Pharma Q1 Net Loss $2.0 Mln Or $0.13/Shr Vs Loss $5.1 Mln Or $0.37/Shr Last Year
5/10/2018 7:35:49 AM Evoke Pharma Says Granted Gender Specific Patent For Gimoti In Mexico
3/26/2018 7:31:41 AM Evoke Announces Deal With Mallinckrodt To Amend Milestone Payments; Cash Runway Extended To January 2019
3/5/2018 7:37:38 AM Evoke Pharma: FDA Approves PDUFA Fee Waiver For Gimoti New Drug Application